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Introduction GABA B receptors are heterodimeric G-protein coupled γ -aminobutyric acid (GABA) receptors comprised of GABA B(1) and GABA B(2) subunits. They are located pre-and postsynaptically, where they modulate neurotransmitter release and slow inhibitory postsynaptic potentials, mainly via actions on presynaptic Ca +2 channels and postsynaptic inwardly rectifying K + channels, respectively, and are also expressed as interneuron autoreceptors (Couve et al., 2000; Bettler et al., 2004) . GABA B receptors are implicated in epilepsy, addiction, pain and gastrointestinal disease . Emerging data also supports a role for GABA B receptors in anxiety, depression Cryan and Kaupmann, 2005; Mombereau et al., 2005) and cognition (Bowery, 2006) . These findings promote further investigations into the mechanisms of action of the GABA B receptors due to their potential importance as a therapeutic target Cryan and Kaupmann, 2005) .
The GABA B(1) gene is transcribed from two different promoter sites to generate two predominant isoforms in the brain: GABA B(1a) and GABA B(1b) (Steiger et al., 2004) ; both of which can heterodimerise with the GABA B(2) subunit to form functional receptors . The two isoforms differ in sequence only by the inclusion of a pair of sushi domains (also called short consensus repeats) at the Nterminus on the GABA B(1a) isoform, which are absent in the GABA B(1b) isoform (Blein et al., 2004) . Other GABA B(1) receptor splice variants have been reported in recombinant systems, although many of these variants are either not expressed in native tissues, or are not evolutionarily conserved across different species, and as such the functional relevance of these variants remains controversial Cryan and Kaupmann, 2005) . The molecular diversity of native GABA B receptors has therefore been regarded as being relatively limited, which is at odds with the reported variability in the nature of responses to GABA B receptor ligands (Marshall et al., 1999; Bettler et al., 2004; Huang, 2006) .
In recombinant systems, many studies attest to a lack of pharmacological differences between the GABA B(1a,2) and GABA B(1b,2) isoforms Malitschek et al., 1998; Brauner-Osborne and Krogsgaard-Larsen, 1999; Green et al., 2000) , although there are also a few findings to the contrary, that differences exist in the pharmacology of the receptor isoforms (see . However, to JPET #111971 5 date, research tools with which to probe the in vivo pharmacology of GABA B(1a) and GABA B(1b) isoforms have not been available. The anatomical expression profile of GABA B(1a) and GABA B(1b) receptor isoforms diverges in many structures (Benke et al., 1999; Bischoff et al., 1999; Liang et al., 2000; Fritschy et al., 2004) , which has given rise to speculation that the isoforms may have functional heterogeneity, possibly meditated by differential synaptic localisation . Furthermore, many studies have shown pharmacological differences between hetero-and autoreceptors, and some GABA B receptor ligands have been postulated to act preferentially at either presynaptic or postsynaptic locations (see Bettler et al, 2004 and Bowery et al., 2002 for reviews). However, the possible contribution of these different isoforms to characteristic in vivo responses to GABA B receptor activation, such as hypothermia and motor performance in response to baclofen (Gray et al., 1987; Jacobson and Cryan, 2005) , are currently unknown.
Recently, mice deficient in the GABA B(1a) and GABA B(1b) subunit isoforms have been generated using a knock-in genetic approach (Vigot et al., 2006) . Electron microscopy and electrophysiological characterisation of the mice revealed that, at least in the hippocampus (Vigot et al., 2006) and in the lateral amygdala (Shaban et al., 2006) , the GABA B(1a) isoform was predominantly a presynaptic heteroreceptor, while the GABA B(1b) isoform was mainly located postsynaptically, and both were autoreceptors (Shaban et al., 2006; Vigot et al., 2006) . In addition, this distribution has been shown to generalise to layer 5 cortical neurons, where the GABA B(1b) isoform was also shown to be predominantly postsynaptically located, while GABA B(1a) was the main isoform represented at presynaptic terminals of local interneurons synapsing on the dendritic tuft (Perez-Garci et al., 2006) . As such, GABA B(1a) -/-and GABA B(1b) -/-mice provide an ideal tool with which to investigate the roles of the two GABA B(1) isoforms in the in vivo pharmacology of GABA B receptor agonist-induced responses. The aim of the present study was therefore to determine the influence of the two GABA B(1) isoforms on both on motor-incoodinating and hypothermic responses to the GABA B receptor agonists baclofen and γ -hydroxybutyrate (GHB), and on baseline locomotor behaviour and body temperature.
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Materials and Methods
Animals and Housing. The generation (Vigot et al., 2006) and breeding strategy of wild-type, GABA B(1a) -/-and GABA B(1b) -/-mice as used in the present studies has been described previously.
Briefly, mice were generated using a knock-in point mutation strategy, whereby GABA B(1a) and GABA B(1b) initiation codons were converted to stop codons by targeted insertion of a floxed neo-cassette. All mutant and wild-type mice were maintained on a pure inbred BALB/c genetic background. GABA B(1a) -/-and GABA B(1b) -/-mice used in the present experiments were derived from homozygous breeding (F3-4) of siblings originating from the founding heterozygotic mice. Homozygous wild-type controls for the GABA B(1) isoform mutant mice were derived from mating together wild-type siblings generated from GABA B(1a) +/-and GABA B(1b) +/-heterozygous breedings (F3-4). The breeding strategy was applied in accordance with the recommendations proposed by The Jackson Laboratory to obviate genetic drift and the formation of substrains (http://jaxmice.jax.org/geneticquality/guidelines.html).
Mice were singly-housed in macrolon cages with sawdust bedding, tissue paper nesting materials and one red, triangular, polycarbonate Mouse House (Nalgene) per cage. Housing was at a constant room temperature of 22-24°C in a 12 h light:dark cycle with lights on at 6 -6.30 am. Food pellets and tap water were available ad libitum (except during experimentation, unless stated). Separate cohorts of mice were used for each experiment. All mice were drug-naïve before experimentation. Male mice were used in all experiments with the exception of GHB-induced hypolocomotion where only females were available. In certain experiments as indicated, experimental replication was also carried out in a cohort of female mice.
All animal experiments were conducted during the light phase with the exception of continuous locomotor activity assessments which were made during both the light and dark phases. All animal experiments were conducted in accordance with Swiss guidelines, and approved by the Veterinary Authority of Basel-Stadt, Switzerland.
Drugs. All drug solutions were prepared freshly prior to use. L-baclofen (Novartis, Basel, Switzerland) and γ -hydroxy-butyrate (GHB, Novartis, Basel, Switzerland) were dissolved in 0.5% methyl cellulose (vehicle) and applied p.o. in a volume of 10 ml/kg. 
Primary Observation Test (POT).
A battery of behavioural and physiological observations were made as previously described to investigate if GABA B(1a) -/-or GABA B(1b) -/-mice had any gross differences compared with wild-type mice. This was important to investigate, as both GABA B(1) -and GABA B(2) -deficient mice have been shown previously to develop an enhanced susceptibility to seizures (Prosser et al., 2001; Schuler et al., 2001) . Mice used in this experiment were singly-housed wild-type, GABA B(1a) -/-and GABA B(1b) -/-mice. The experiment was replicated separately in both male and female mice. The mean age (± SEM) of the mice was 20.0 ± 1.0 weeks for males and 23.1 ± 0.8 weeks for females (n = 11-12 for each genotype and gender). The observations quantified were the presence of twitches, tremor, convulsions, piloerection, stereotyped behaviour, lacrimation, salivation, ptosis, catalepsy, passivity, falling convulsion and ataxia. In addition the frequency and quality of breathing was observed. Alterations in skin colour, tail position, pelvic position, limb tonus, abdominal tonus and pupil width were observed.
The nature of locomotion, motility and rearing in the home cage were quantified as were their overall flight and startle reactions. In addition novelty behaviour was observed and a series of reflexes checked, including pinna reflex, toepinch, tailpinch and provoked biting. Body temperature was also quantified. This battery of tests has been validated in our laboratories to detect stimulant and sedative effects in mice in addition to other effects of pharmacological agents.
Locomotor Activity of GABA B(1a) -/-, GABA B(1b) -/-and Wild-Type Mice in a Novel Environment.
Locomotor activity of mutant and wild-type mice when placed in a novel environment was investigated in two separate experiments with male and female mice, respectively. Horizontal locomotor activity of the mice (n = 10-11 for each genotype and sex, mean age (± SEM ) was 17.5 (± 0.5) and 14.5 (± 0.4) weeks for males and females, respectively) was recorded for 1 hour after individuals were placed into novel enclosure (transparent Plexiglas boxes, 19 x 31 x 16 cm), with motion detection determined by infrared light beam interruptions along the x-y axes. Distance travelled was automatically calculated using a TSE Moti system (TSE, Bad Homburg, Germany). Female mice: n = 18 -21 per genotype, mean age (± SEM) 18 ± 0.3 weeks). In the second cohort, 0 and 6 mg/kg of L-baclofen was examined (male mice: n = 9 -10 per genotype, mean age (± SEM) 15.2 ± 0.3 weeks. Female mice: n = 8 -10 per genotype, mean age (± SEM) 25.2 ± 0.5 weeks).
Continuous 3-Day Locomotor
In the experimental protocol, performance on the fixed-speed rotarod (Dunham and Miya, 1957) was combined with the evaluation of rectal temperature within each animal, as previously described Jacobson and Cryan, 2005) . The rotarod apparatus consisted of a 280 mm diameter rod of approximately 3000mm length, which was partitioned into 5 lanes of 580 mm wide to accommodate individual mice. The rod was positioned 30 cm above a surface and rotated at a constant speed of 12 rpm.
Each day the rod lanes were tightly lined with fresh paper towelling. Two days prior to testing, the Mouse House and tissue paper nesting materials were removed from each cage to reduce possible inter-cage variations in mouse body temperatures on the day of testing. On the day prior to testing mice were acclimatized to the rectal thermistor probe by performing a single body temperature measurement and were then trained to walk on the rotarod for 300 seconds. Rotarod training was performed in two to four sessions, depending on the innate ability of each animal. The number of falls during training was recorded. Mice were returned to the home cage for an interval of about 30 minutes between training sessions.
On the day of testing, mice were moved to the experimental lab at least 2 hours before dosing. One hour before dosing, rectal temperature was taken. At time 0 hr, rectal temperature was taken, then the mice were placed on the rotarod for 300 seconds to re-establish training and to provide an experimental baseline.
Each mouse was then immediately dosed with their allocated treatment on completing 300 seconds on the rotarod. One, two and four hours thereafter rectal temperature and endurance on the rotarod were recorded.
An index of the degree of hypothermia (summed ∆ T) was calculated by totalling the differences between control (pre-dose) rectal temperature and the temperatures at 1, 2 and 4 hours post treatment, respectively, within each animal. An index of the degree of ataxia was calculated by determining the difference between cumulative total time on the rotarod 1, 2 and 4 hours after drug or vehicle application as a proportion of the total possible (i.e. percent reduction from 1200 seconds). and Wild-Type Mice. The effect of GHB (1 g/kg) on body temperature has been shown to be GABA B (1) receptor dependent (Kaupmann et al., 2003) . Therefore, we assessed whether either receptor isoforms conferred susceptibility to GHB-induced hypothermia. This dose was selected based on our dose-response data obtained in BALB/c mice (Kaupmann et al., 2003) , the background strain for the GABA B(1) isoform mutant and wild-type mice. Rectal temperature (ELLAB Instruments thermistor probe, as described above) of singly-housed, age-matched, male mice (n: WT = 7; GABA B(1a) -/-= 9; GABA B(1b) -/-= 13; mean age (± SEM) 27.0 ± 1.7 weeks) was recorded 1 hour prior to, immediately before, and 30, 60, 120 and 240 minutes after, per os administration of GHB (1 g/kg in methyl cellulose (0.5%)) in a volume of 10 ml/kg.
Effect of
This article has not been copyedited and formatted. The final version may differ from this version. (Kaupmann et al., 2003) . Therefore, it was important to assess whether either of the GABA B(1) receptor subunit isoforms conferred susceptibility to GHB-induced hypoactivity. Singlyhoused, age-matched, female mice (n: WT = 23; 1a-/-= 16; 1b-/-= 34, mean age (± SEM) 26.7 ± 0.6 weeks) were given GHB (1 g/kg) or vehicle (0.5% methyl cellulose) per os in a volume of 10 ml/kg. The doses of GHB was selected based on previous dose-response studies showing maximal effects at this dose in this background mouse strain (Kaupmann et al., 2003) . One hour after dosing, mice were placed in a transparent Plexiglas boxes (19 x 31 x 16 cm), and motion detection was determined over the following hour by infrared light beam interruptions along the x-y axes. Distance travelled was automatically calculated using a TSE Moti system (TSE, Bad Homburg, Germany).
Statistical Analyses.
As studies which were carried out in both male and female mice were conducted in independent experiments, data for each sex were analysed separately. Live-weight and rectal temperature as determined in the POT were analysed with 1-way ANOVA. Locomotor activity in a novel environment and continuous 3-day locomotor activity were analysed for the effects of genotype and time using 2-way repeated measures (RM) analysis of variance (ANOVA). Summed mean distance travelled during the first 2 and the full 12 hours of the 3 complete dark cycles and during the 12 hours of the two complete light cycles, were analysed for the effect of genotype using 1-way ANOVA. Basal body temperature (at time points -1 and 0 hr in the combined rotarod -temperature experiment) were analysed for the effect of replicate, genotype and time using 3 -way ANOVA. Fisher's LSD post hoc comparisons were made where indicated by significant ANOVA factors. Falls during rotarod training, and body temperature responses to GHB were analysed for the effect of genotype in a pair-wise fashion using the Mann-Whitney Rank Sum method. All variables from the POT, with the exception of live-weight and rectal temperature (see above), summed rotarod data (within each baclofen dose) and distance travelled after vehicle or GHB (Schuler et al., 2001; , this phenotype was not behaviourally apparent in GABA B(1a) -/-or GABA B(1b) -/-mice. To assess whether ablation of GABA B(1a) or GABA B(1b) receptor isoforms had any other effects on gross behaviour and physiology, male and female GABA B(1a) -/-or GABA B(1b) -/-mice were subjected to an extensive POT battery.
Within the male mice, GABA B(1b) -/-mice were significantly heavier than either wild-type (P < 0.01) or GABA B(1a) -/-(P < 0.001) mice, and wild-type mice were heavier than GABA B(1a) -/-mice (P < 0.001).
Mean (± SEM) weights of male mice were: wild-type, 32.5 (± 0.6) g; GABA B(1a) -/-, 29.2 (± 0.5) g;
GABA B(1b) -/-, 34.8 (±0.6) g (Genotype F 2,34 = 23.73, P < 0.001).
Female GABA B(1b) -/-mice were slightly, but significantly heavier than female wild-type mice (P < 0.01, mean (± SEM) weights were 27.6 ± 0.7 g and 24.5 ± 0.7 g, respectively). However, there were no differences between the weight of female GABA B(1a) -/-mice (25.9 ± 0.8 g) and either wild-type or GABA B(1b) -/-female mice (Genotype F 2,35 = 4.20, P < 0.05).
The POT battery otherwise revealed no significant differences between GABA B(1a) -/-, GABA B(1b)
-/-and wild-type mice in any of the other thirty one parameters assessed (see materials and methods). This included body temperature as assessed in the home cage, where mean rectal temperature for both the male and female mice was not significantly influenced by genotype, respectively (males: mean rectal temperature ± SEM: 35.9 ± 0.13 °C; Genotype Genotype influenced the pattern of locomotor activity in male mice (Time F 11, 347 = 15.39, P < 0.001; Genotype F 2, 347 = 1.67, P > 0.05; Interaction F 22, 347 = 1.708, P < 0.05; Fig. 1a) . Post hoc analysis revealed the male GABA B(1b) -/-mice were more active than wild-type and GABA B(1a) -/-male mice within the first 5 minutes, and at other time-points within the first 20 minutes of the experiment (Fig. 1a) . Male GABA B(1b) -/-mice travelled significantly greater distances that either wild-type of GABA B(1a) -/-mice during the first hour of habituation to a new enclosure, and during the following three dark phases, while GABA B(1a) -/-mice travelled similar distances to that of wild-type mice during the dark phases (Genotype F 2, 1607 = 2.62, P = 0.096; Time F 66, 1607 = 34.08, P < 0.001; Interaction F 132, 1607 = 1.75, P < 0.001; Fig. 2a and   b ). The activity of the GABA B(1b) mice was particularly prevalent during the first 2 hours of the dark phase, as the distance travelled (averaged over the 3 dark phases and expressed as a proportion the wild-type mean) during this time was 154% that of the wild-type controls (Gentoype: F 2,23 = 6.697, P < 0.01 Fig. 2c ). This pattern of behavior was confirmed when assessing data as mean summed distance (within animal) in the dark, as GABA B(1b) -/-mice travelled a greater mean distance during the dark phase than either wild-type or GABA B(1a) -/-mice (P < 0.05, respectively. Genotype F 2, 23 = 3.81, P < 0.05, Fig. 2d.) . In comparison, during the two complete light phases, the GABA B(1a) -/-mice travelled a greater mean distance per light phase than the wild-type mice (Genotype F 2, 23 = 4.15, P < 0.05, Fig 2e) . Baclofen produced profound, long lasting hypothermia in male wild-type mice (male wild-types:
Baclofen dose F 2,149 = 13.74, P < 0.001; Time F 4,149 = 13.99, P < 0.001; Interaction F 8,149 = 16.36, P < 0.001, Baclofen also induced time-dependent hypothermia in female wild-type mice (female wild-types:
Baclofen dose F 2,129 = 52.85, P < 0.001; Time F 4,129 = 18.17, P < 0.001; Interaction F 8,129 = 18.11, P < 0.001; Fig. 3g ). However, the degree of hypothermia was greatly attenuated in both mutant strains of mice in comparison to the wild-type mice. As for the experiment using the male mice, this attenuation was particularly apparent when examining the summed hypothermic responses to baclofen. The degree of summed hypothermia in response to 12 mg/kg of baclofen was greatly attenuated in both mutant strains of female mice in comparison to the wild-types, but did not differ significantly between the two mutant lines (Females: Genotype F 2,86 = 26.09, P < 0.001;
Baclofen dose F 2,86 = 50.78, P < 0.001; Interaction F 4,86 = 15.19, P < 0.01; Fig. 3h ).
It is interesting to note that in the experiments with both male and female GABA B(1b) -/-mice, the lower dose of baclofen appeared to induce hyperthermia 1 hour after baclofen administration ( Fig. 3c and   3g ). In the female mice, post hoc analysis within the 6 mg/kg group showed significant increase in body temperature from the -1 to the 0 hour time-point (P < 0.01), and a tendency to further increase from the 0 to the 1 hour time-point (P = 0.077). In male mice, post hoc analysis within the 6 mg/kg baclofen treatment, similar to the females, showed a significant increase in body temperature from the -1 to the 0 hour time- 
Discussion
The Gabbr1 gene is predominantly transcribed into two differentially expressed isoforms, GABA B(1a) and GABA B(1b) , which differ in sequence primarily by the inclusion of a pair of evolutionary conserved sushi repeats (a.k.a. short consensus repeats) in the GABA B(1a) N-terminus . were more active throughout the dark phase than either the GABA B(1a) -/-or wild-type mice. Finally, the findings of the lack of overt phenotype in the POT, similar attenuation of baclofen-induced hypothermia and ataxia in both mutants, and hyperlocomotor responses to a novel environment by GABA B(1b) -/-mice were replicated in separate experiments with both male and female mice, attesting to the reproducibility of these phenotypes.
GABA B receptors play a crucial role in mediating normal motor responses (Jacobson and Cryan, 2005) . Further, deletion of the GABA B1 receptor subunit results in a complex locomotor response Vacher et al., 2006) . This includes marked hyperlocomotion when exposed to a novel environment whereas in a familiar environment, GABA B(1) -/-mice display an altered pattern of circadian activity but no hyperlocomotion . Therefore, the baseline motor hyperactivity of GABA B(1b) -/-mice in a novel environment was not entirely surprising. Although the effect of GABA B (1b) This article has not been copyedited and formatted. The final version may differ from this version. isoform deletion on locomotor activity appeared somewhat modest, the magnitude of the effect is more apparent when examined as a relative proportion of the wild-type controls. For example, male GABA B(1b) -/-mice travelled approximately 140% of the distance of wild-type controls in the first five minutes of exposure to a novel environment, and 154% of that of wild type mice in the first 2 hours of the dark cycle.
Furthermore, hyperlocomotor responses were demonstrated on four occasions with three different cohorts of mice: novelty-induced hyperlocomotion was replicated in a separate cohort of female mice; in another cohort of male mice in the 3 day locomotor experiment during the first hour in a new home cage, and;
hyperlocomotion of GABA B(1b) -/-in the dark phase was subsequently demonstrated during the following three dark cycles. Together these data suggest that the loss of the GABA B(1b) isoform may contribute to a significant degree to the aforementioned hyperlocomotion of GABA B(1) -/-mice.
Although the locomotor behaviour of GABA B(1a) -/-mice was similar to wild-type controls in the present investigation, in other test systems differences to wild-type and GABA B(1b) -/-mice have been identified. We have previously shown that GABA B(1a) -/-mice were impaired in an object recognition task (Vigot et al., 2006) , whereas the GABA B(1b) -/-mice were not. Further, GABA B(1a) -/-mice had deficits in the acquisition of conditioned taste aversion and in the generalisation of fear conditioning-induced freezing (Shaban et al., 2006) . Correspondingly, the GABA B(1a) -/-, but not the GABA B(1b) -/-, mice were also deficient in hippocampal (Vigot et al., 2006) and amygdala LTP (Shaban et al., 2006) . In addition, Perez-Garci et al., (2006) have also demonstrated specific and differential roles for the GABA B(1a) and GABA B(1b) isoforms in mediating different components of GABA B receptor -induced inhibition of layer 5 cortical neurons. Together with the hyperactive phenotype in locomotor activity of the GABA B(1b) -/-mice shown in the present study, these data demonstrate that GABA B(1) receptor isoforms have divergent and functionally relevant influences on behavioural output and the underlying neurophysiology.
Given the phenotypic differences between these two isoform-deficient lines of mice, it was interesting to note that although both GABA B ( seen in wild-type mice (Schuler et al., 2001; Queva et al., 2003) . This indicated that the full GABA B receptor heterodimer is necessary for the actions of these agonists, and likewise, that the actions of these agonists are specific to the GABA B receptor. Results of the present study, however, suggest that neither the GABA B(1a) nor GABA B(1b) isoforms are solely responsible for the hypothermic or ataxic actions of baclofen. The data also show that neither isoform can fully compensate for the loss of the other with regard to agonist-induced responses. To further confirm this we investigated the effects of another GABA B receptor agonist, GHB. We have previously shown that the hypothermic and motor-impairing effects of GHB (1g/kg) are completely absent in mice lacking the GABA B(1) receptor (Kaupmann et al., 2003 ). Here we demonstrate that the effects of GHB were modestly but significantly attenuated in mice lacking either of the two GABA B(1) isoforms. Thus, we can conclude, as in the case of baclofen, that neither the GABA B(1a) nor GABA B(1b) isoforms are solely responsible for the hypothermic or ataxic actions of GHB. This in vivo data is in support of a number of recombinant studies which demonstrate neither baclofen nor GHB appear to show specificity for either one of the two predominant GABA B(1) subunit isoforms (see .
Paradoxically, at the lower dose of 6 mg/kg, baclofen appeared to increase body temperature in GABA B(1b) -/-mice. Examination of post-hoc statistical comparisons indicated that the bulk of the temperature increase of mice in this treatment group occurred between time -1 and 0 hours -both of which preceded baclofen injection. It therefore seems likely that handling stress may have induced the apparent hypothermic responses in these mice. However, it should be noted that the GABA B agonist GHB at low doses has been previously reported to induced hyperthermia as opposed to hypothermia (Kaufman et al., 1990) . It therefore remains possible that some influence of residual GABA B(1) activity in the GABA B(1b) -/-mice may have contributed to a hyperthermic response to baclofen in these mice.
Control of body temperature and motor activity is anatomically and neurochemically heterogeneous (Cryan et al., 1999; Cryan et al., 2000; Jacobson and Cryan, 2005) . Both GABA B(1a) and GABA B(1b) isoforms are abundantly expressed throughout the brain, although their expression level relative to each other and distribution profile within structures diverges in many regions, including in many of those This article has not been copyedited and formatted. The final version may differ from this version. involved in the control of body temperature or motor activity and coordination (Benke et al., 1999; Bischoff et al., 1999; Liang et al., 2000; Fritschy et al., 2004) . It may therefore seem reasonable to have expected that, irrespective of a lack of specificity of the isoforms for baclofen or GHB, responses to the agonists may yet have varied between the two mutant mouse lines. In the present study, however, this was not the case.
Previously we have demonstrated that genetic background (in the form of different mouse strains) can greatly influence hypothermic and ataxic responses to baclofen (Jacobson and Cryan, 2005) . The present study may indicate that this is not necessarily due to overall variations in the relative expression of the GABA B(1) subunit isoforms. Indeed, given that baseline body temperatures of the GABA B(1a) -/-and GABA B(1b) -/-mice showed negligible differences, it may be that normal homeostasis of body temperature is not specifically controlled by one or other of the GABA B(1) subunit isoforms either. This is in contrast to the full GABA B(1) -/-mice, where basal body temperature was shown to be approximately 1°C lower that of the wild-type controls (Kaupmann et al., 2003; Queva et al., 2003) .
The lack of differential responses to baclofen and GHB between the GABA B(1) isoform-deficient mice may also be due in part to the complex neural control of body temperature and motor activity. For example, when strongly activated by pharmacological means, loss of either presynaptic or postsynaptic inhibition in a complex multisynaptic system may ultimately appear similar downstream i.e., appearing as an increase in excitability in a convergent output. With regard to the contribution of different cellular components in these systems, the prospective roles of interneurons in GABA B receptor agonist-induced hypothermia and ataxia are unknown at the present time. Hippocampal and lateral amygdala autoreceptor function was preserved in both GABA B(1a) -/-and GABA B(1b) -/-mice (Shaban et al., 2006; Vigot et al., 2006) , but was completely absent in the GABA B(1) -/-mice (Prosser et al., 2001; Schuler et al., 2001 ). This indicated that in these structures, both isoforms can act as autoreceptors. However, GABAergic interneurons synapsing on distal dendrites of layer 5 cortical neurons appeared to preferentially express the GABA B(1a) isoform, but not the GABA B(1b) isoform (Perez-Garci et al., 2006 receptor-mediated hypothermia and ataxia.
In conclusion, GABA B(1a) and GABA B(1b) isoforms are functionally relevant molecular variants of the GABA B(1) receptor subunit, which are differentially involved in specific neurophysiological processes and behaviors. It is evident from the present study, however, that the GABA B receptors agonists baclofen and GHB were unable to pharmacologically discriminate these differences, at least with regard to body temperature and motor coordination. As the sequence of the GABA B(1a) and GABA B(1b) isoforms differ primarily in the N-terminus, and not in the region coding the ligand binding domain (Kaupmann et al., 1997; Bettler et al., 2004) , future studies should focus on strategies to uncover novel interaction sites at either receptor isoforms in order to enable specific pharmaceutical intervention.
This article has not been copyedited and formatted. The final version may differ from this version. . Note: analysis performed with nonparametric testing. + P < 0.10 GHB-treated 1b -/-vs WT; * P < 0.05, GHB-treated 1a -/-vs WT.
